4281 - 4290 of 8808 Results
Title
Year
-
OPENTitle: Mechanism of Activation of the Ubiquitin E3 Ligase, ParkinJournal Name: The FASEB JournalPublisher: WileyVol: 34Issue #: S1Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fasebj.2020.34.s1.07607Citation Count: 0
-
OPENTitle: INVESTIGATING MOTOR LEARNING IN A LRRK2 MOUSE MODEL OF PARKINSON’S DISEASEJournal Name: The FASEB JournalPublisher: WileyVol: 34Issue #: S1Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fasebj.2020.34.s1.04831Citation Count: 0
-
OPENTitle: A Novel Parkinson’s Disease Model: PINK1/PARKIN Double‐Knockout RatsJournal Name: The FASEB JournalPublisher: WileyVol: 34Issue #: S1Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fasebj.2020.34.s1.03409Citation Count: 0
-
OPENTitle: Parkinson's Disease Research on the African Continent: Obstacles and OpportunitiesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page: 512End Page: 512Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00512Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00512/pdfCitation Count: 34
-
OPENTitle: LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 577End Page: 577Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00577Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00577/pdfCitation Count: 70
-
OPENTitle: Editorial: Protein Degradation Pathways in Parkinson's Disease and NeurodegenerationJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00741Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00741/pdfCitation Count: 0
-
RESTRICTEDTitle: Tears – More to Them Than Meets the Eye: Why Tears Are A Good Source of Biomarkers in Parkinson'S DiseaseJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 14Issue #: 2Start Page: 151End Page: 163Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/bmm-2019-0364Citation Count: 19
-
OPENTitle: Application of the ‘5-2-1’ Screening Criteria in Advanced Parkinson’s Disease: Interim Analysis of DUOGLOBEJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 10Issue #: 5Start Page: 309End Page: 323Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/nmt-2020-0021Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/17e77252-07a9-4a0c-bf27-17619e38abb5Citation Count: 45
-
RESTRICTEDTitle: Effects of a community-based Exercise Program On mobility, balance, cognition, sleep, Activities of Daily living, and Quality of Life in PD: A Pilot StudyJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 10Issue #: 1Start Page: 27End Page: 39Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/nmt-2019-0027Citation Count: 19
-
OPENTitle: Microgravity: A Tool for Protein Drug DevelopmentJournal Name: International Journal of Pharmaceutical Sciences Review and ResearchPublisher: Global Research OnlineVol: 64Issue #: 2Start Page: 82End Page: 86Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.47583/ijpsrr.2020.v64i02.014Best OA location URL: https://doi.org/10.47583/ijpsrr.2020.v64i02.014Citation Count: 5